
Harmony Biosciences Holdings HRMY
€ 24.34
2.97%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Harmony Biosciences Holdings ROA 2011-2026 | HRMY
ROA Jährlich Harmony Biosciences Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.48 | 14.56 | 15.88 | 26.93 | 7.98 | -8.65 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 26.93 | -8.65 | 11.53 |
ROA Vierteljährlich Harmony Biosciences Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.08 | 17.84 | 15.6 | 10.84 | 15.79 | 15.77 | 18.93 | 13.58 | 27.25 | 35.97 | 36.09 | 22.93 | 20.47 | -0.29 | 3.64 | 3.65 | 4.1 | 7.01 | 3.08 | -8.6 | -38.5 | -68.84 | -68.83 | -29.9 | -29.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 36.09 | -68.84 | 1.79 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Amgen
AMGN
|
8.51 | $ 350.13 | 2.98 % | $ 188 B | ||
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | ||
|
Amneal Pharmaceuticals
AMRX
|
1.96 | $ 12.73 | 3.33 % | $ 3.99 B | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
argenx SE
ARGX
|
-14.32 | $ 783.17 | 2.32 % | $ 25 B | ||
|
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.48 | 8.82 % | $ 394 M | ||
|
Applied Therapeutics
APLT
|
-218.41 | - | - | $ 8.42 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 24.57 | 5.59 % | $ 3.13 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
BioNTech SE
BNTX
|
65.02 | $ 91.64 | 2.25 % | $ 27.2 B | ||
|
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.82 | 1.6 % | $ 9.19 B | ||
|
Burford Capital Limited
BUR
|
5.51 | $ 4.62 | 1.54 % | $ 742 M | ||
|
CymaBay Therapeutics
CBAY
|
-24.24 | - | - | $ 3.45 B | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
-10.92 | $ 2.68 | 4.28 % | $ 16.8 M | ||
|
Avid Bioservices
CDMO
|
-41.82 | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
-79.06 | - | - | $ 1.41 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 3.05 | 0.66 % | $ 6.64 B | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Cabaletta Bio
CABA
|
-101.68 | $ 3.05 | -0.5 % | $ 306 M | ||
|
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | ||
|
Cerus Corporation
CERS
|
-7.04 | $ 1.93 | 4.62 % | $ 368 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
Concert Pharmaceuticals
CNCE
|
-48.42 | - | - | $ 401 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
CTI BioPharma Corp.
CTIC
|
-73.85 | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-36.63 | - | -4.36 % | $ 27 M | ||
|
Cellectar Biosciences
CLRB
|
-145.48 | $ 2.83 | 2.91 % | $ 7.38 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-41.16 | - | - | $ 2.18 B | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Dynavax Technologies Corporation
DVAX
|
2.77 | - | - | $ 2.02 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Coherus BioSciences
CHRS
|
65.04 | $ 1.73 | 3.59 % | $ 203 M |